Can we predict the risk factors for switching due to ineffectiveness in the first year of therapy with bDMARD in patients with rheumatoid arthritis? Ana Martins; Sofia Pimenta; Daniela Oliveira; Rafaela Nicolau; Alexandra Bernardo; Teresa Martins Rocha; Lúcia Costa; Miguel Bernardes;

Study of the impact of the inclusion of global pain and functional capacity assessment in the definition of remission and its maintenance for rheumatoid arthritis. Aims and methodology Alejandro Balsa; Daniel Seoane-Mato; Marta Domínguez-Álvaro; Mercedes Alperi; Virginia Ruiz-Esquide; Javier Bachiller-Corral; Federico Díaz-González;

Raoul Dufy: Color and resilience in the fight against rheumatoid arthritis Fernando Canillas; Marta Canillas;